AS

Abhaysingh Shivaji Patankar

Active Director Director DIN 07963346
DIN 07963346 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Abhaysingh Shivaji Patankar

Data last updated:

Abhaysingh Shivaji Patankar is a Director at Celesten Biopharmaceuticals Private Limited (since 2021). The company operates in Pharma. Celesten Biopharmaceuticals Private Limited reported revenue of ₹13.4 Lakh (FY 2025).

DIN 07963346
Primary Designation Director
Industry Pharma
First Appointment 08 Jan 2021
Oldest Company Age 9 yrs
Largest company Celesten Biopharmaceuticals Private Limited · ₹13.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jan 20212017₹13.4 Lakh (FY 2025)Active

Board colleagues of Abhaysingh Shivaji Patankar

Directorship timeline

Open interactive timeline →
Celesten Biopharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abhaysingh Shivaji Patankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhaysingh Shivaji Patankar

Abhaysingh Shivaji Patankar currently holds 1 directorship: Celesten Biopharmaceuticals Private Limited (Director, since 08 Jan 2021, revenue ₹13.4 Lakh (FY 2025)).

Abhaysingh Shivaji Patankar was first appointed on 08 Jan 2021 as Director at Celesten Biopharmaceuticals Private Limited.

The current boards of Abhaysingh Shivaji Patankar's companies include Anita Shivaji Patankar (Celesten Biopharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available